LivaNova Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Vladimir Makatsaria
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 2.9yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08
Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19A Look At The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Jun 27LivaNova Matures Into Profitability, Still Waiting On DTD
May 10Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Apr 05LivaNova Continues To Be A Spring-Loaded Opportunity In Neuromodulation
Feb 11Is LivaNova PLC (NASDAQ:LIVN) Trading At A 35% Discount?
Jan 30At US$87.75, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Dec 29Does LivaNova (NASDAQ:LIVN) Have A Healthy Balance Sheet?
Nov 29Milan Court Decision Does Not Change LivaNova Bullish Story
Nov 16CEO
Vladimir Makatsaria (50 yo)
less than a year
Tenure
Mr. Vladimir A. Makatsaria has been the Chief Executive Officer and Director at LivaNova PLC since March 01, 2024. Mr. Makatsaria served as Company Group Chairman at Johnson & Johnson MedTech, leading its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 3.5yrs | US$2.13m | 0.033% $ 980.6k | |
| Chief Human Resources Officer | 5.1yrs | US$1.69m | 0.026% $ 758.2k | |
| CEO & Director | less than a year | no data | no data | |
| Chief Technology Officer | less than a year | no data | no data | |
| Senior Director of Investor Relations | no data | no data | no data | |
| Senior VP | 1.4yrs | no data | 0.0042% $ 125.9k | |
| Vice President of Corporate Communications | no data | no data | no data | |
| Senior Vice President of Corporate Development & IT | 6.3yrs | no data | no data | |
| Senior VP & Head of Product Development - Neuromodulation | no data | no data | no data | |
| President of Advanced Circulatory Support | 2.3yrs | no data | no data | |
| President of Global Epilepsy | 4.3yrs | no data | 0.018% $ 526.0k | |
| Vice President of Sleep Apnea and Epilepsy | no data | no data | no data |
2.9yrs
Average Tenure
52yo
Average Age
Experienced Management: LIVN's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Non-Executive Director | 3.3yrs | US$269.96k | 0.0073% $ 217.9k | |
| Independent Director | 1.8yrs | US$203.04k | 0.0030% $ 90.0k | |
| Chairman of Board | 5.8yrs | US$389.99k | 0.051% $ 1.5m | |
| Independent Non-Executive Director | 8.5yrs | US$257.71k | 0.015% $ 444.1k | |
| Independent Non-Executive Director | 4.8yrs | US$259.96k | 0.012% $ 365.7k | |
| Independent Director | 9.3yrs | US$247.06k | 0.051% $ 1.5m | |
| Independent Non-Executive Director | 8.5yrs | US$262.96k | 0.015% $ 449.8k | |
| Director | less than a year | no data | no data | |
| Independent Director | 1.6yrs | US$130.76k | 0.0026% $ 76.0k |
4.8yrs
Average Tenure
62yo
Average Age
Experienced Board: LIVN's board of directors are considered experienced (4.8 years average tenure).